Business · 24/09/2026

Fisher Clinical Services, Inc. Seeks Registration as Controlled Substance Importer

Fisher Clinical Services, Inc. has submitted an application to the authorities to be registered as an importer of controlled substances, a move that could potentially impact the pharmaceutical industry.

Source: Federal Register — Justice DepartmentOpen original release →

Find a company or service

Business Communicator helps companies present their offer, publish updates and connect directly.

Create a company profile Explore businesses on Business Maps →

LATEST SIGNALS

Business · 10/19/2026

Mabwell to Present Clinical Results for Nectin-4-Targeting ADC 9MW2821 in ADC-Pretreated Triple-Negative Breast Cancer

Mabwell, a biopharmaceutical company, will present Phase II clinical data on its Nectin-4-targeting ADC 9MW2821 for ADC-pretreated triple-negative breast cancer patients, following its presentation at the ESMO 2026 conference

Read summary →

Business · 10/18/2026

Aura to Release Q3 2026 Earnings Call and Quarterly Results on November 12th

Aura, a global leader in online safety and wellbeing, will release its Q3 2026 financial results on November 12th, 2026, prior to the opening of the ASX market.

Read summary →

Business · 10/18/2026

Valley Hi Toyota's Zombie Series Finale: 'The Rawr Family' Wedding Episode to Air on Halloween

Valley Hi Toyota is concluding its decade-long Zombie Series with a Halloween-season finale, 'The Rawr Family' wedding episode, and invites fans to vote for their favorite and enter a contest

Read summary →

Business · 10/18/2026

AbbVie to Present Data at the 2026 European Society for Medical Oncology (ESMO) Congress Highlighting Progress Across its Expanding Solid Tumor Portfolio

AbbVie is set to present new and updated data on its expanding portfolio of treatments for various types of cancer, including lung, colorectal, ovarian, prostate, and gastric cancers, at the 2026 ESMO Congress, showcasing the potential of its next-generation antibody-drug conjugates (ADCs) to address diverse patient needs.

Read summary →

Business · 10/18/2026

Lilly to Showcase Advances Across Its Oncology Pipeline at the 2026 European Society for Medical Oncology (ESMO) Congress

Lilly will present early-stage data from its investigational treatments for ovarian cancer and other cancers at the 2026 ESMO Congress, highlighting its oncology pipeline progress.

Read summary →

Business · 10/18/2026

Antibiotic Use in Childhood Linked to Higher Odds of IBS in Young Adulthood, Study Finds

A new study published in Spain found that children who used antibiotics from a young age were more likely to develop irritable bowel syndrome (IBS) by age 24, with the risk increasing with the number of antibiotic prescriptions

Read summary →